Protara Therapeutics, Inc. (TARA) stock
TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.34+0.02 (+0.86%)
Close on Nov 18, 2026Market cap $138.28MP/E –Yield –
Protara Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Protara Therapeutics's price to book ratio was 1.0× on Nov 11, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 0.2× to 2.2×, with a median of 0.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | −0.6 |
| 2025 | Dec 31, 2025 | 1.6× | +0.2 |
| 2024 | Dec 31, 2024 | 1.3× | +1.1 |
| 2023 | Dec 29, 2023 | 0.3× | +0.1 |
| 2022 | Dec 30, 2022 | 0.2× | −0.2 |
| 2021 | Dec 31, 2021 | 0.4× | −0.9 |
| 2020 | Dec 31, 2020 | 1.3× | −26.9 |
| 2019 | Dec 31, 2019 | 28.2× | +26.4 |
| 2018 | Dec 31, 2018 | 1.8× | +0.9 |
| 2017 | Dec 29, 2017 | 0.8× | +0.1 |
| 2016 | Dec 30, 2016 | 0.7× | −3.0 |
| 2015 | Dec 31, 2015 | 3.7× | – |
See a number that looks wrong?